References
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973.
- Hansen TJ, Lucking S, Miller JJ, et al. Standardized laboratory monitoring with use of isotretinoin in acne. J Am Acad Dermatol. 2016;75(2):323–328.
- Shah R, Kroshinsky D. Re-evaluating the need for routine laboratory monitoring in isotretinoin patients: a retrospective analysis. J Am Acad Dermatol. 2018; [cited 2019 Jun 8]; [4].
- Hobson JG, Cunningham MJ, Lesiak K, et al. Isotretinoin monitoring trends: a national survey of dermatologists. J Drugs Dermatol. 2017;16(6):557–564.
- Lee YH, Scharnitz TP, Muscat J, et al. Laboratory monitoring during isotretinoin therapy for acne: a systematic review and meta-analysis. JAMA Dermatol. 2016;152(1):35–44.
- Oktem A, Hayran Y, Ari E, et al. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris. J Dermatolog Treat. 2019; [cited 2019 Jun 8]; [15].
- Tapper E, Saini S. Too many patients gt liver tests they don’t need, which can raise fears and costs, research shows. IHPI News [Internet]. 2017 Mar 2 [cited 2019 Jun 8];[about 4 screens]. Available from: https://ihpi.umich.edu/news/too-many-patients-get-liver-tests-they-don%E2%80%99t-need-which-can-raise-fears-costs-research-shows